Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wang Lai, holds the title of President, Global Head of R&D at BeOne Medicines Ltd..
On 2026-06-23, the insider transacted 1,068 shares.The price in this filing could not be confirmed (company reports from abroad; currency could not be checked), so no dollar value is shown. The SEC filing has the figures as filed.
Wang Lai (President, Global Head of R&D) sold shares of $ONC (value not verified)
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.